107 related articles for article (PubMed ID: 11230752)
1. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
Yee LJ; Tang J; Gibson AW; Kimberly R; Van Leeuwen DJ; Kaslow RA
Hepatology; 2001 Mar; 33(3):708-12. PubMed ID: 11230752
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
Shaker OG; Abdel-Rahim MT; Bayoumi ST
Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
[TBL] [Abstract][Full Text] [Related]
3. Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.
Yee LJ; Perez KA; Tang J; van Leeuwen DJ; Kaslow RA
J Infect Dis; 2003 Apr; 187(8):1264-71. PubMed ID: 12696006
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa.
Wang S; Huang D; Sun S; Ma W; Zhen Q
Virol J; 2011 Jan; 8():28. PubMed ID: 21251301
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.
Rosen HR; McHutchison JG; Conrad AJ; Lentz JJ; Marousek G; Rose SL; Zaman A; Taylor K; Chou S
Am J Gastroenterol; 2002 Mar; 97(3):714-20. PubMed ID: 11922568
[TBL] [Abstract][Full Text] [Related]
6. Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism.
Schiemann U; Glas J; Török P; Simperl C; Martin K; König A; Schmidt F; Schaefer M; Folwaczny C
Digestion; 2003; 68(1):1-4. PubMed ID: 12949432
[TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection.
El-Karaksy HM; Sharaf SA; Mandour IA; Mogahed EA; Rady NH; El-Mougy FA
Hum Immunol; 2016 Dec; 77(12):1248-1253. PubMed ID: 27660094
[TBL] [Abstract][Full Text] [Related]
8. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
[TBL] [Abstract][Full Text] [Related]
9. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
Romero-Gómez M; González-Escribano MF; Torres B; Barroso N; Montes-Cano MA; Sánchez-Muñoz D; Núñez-Roldan A; Aguilar-Reina J
Am J Gastroenterol; 2003 Jul; 98(7):1621-6. PubMed ID: 12873589
[TBL] [Abstract][Full Text] [Related]
10. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
11. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Gartung C; Lorenzen J; Matern S; Lammert F
Hepatology; 2004 Aug; 40(2):327-34. PubMed ID: 15368437
[TBL] [Abstract][Full Text] [Related]
12. Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy.
Khan AJ; Saraswat VA; Choudhuri G; Parmar D; Negi TS; Mohindra S
Epidemiol Infect; 2015 Jan; 143(1):71-80. PubMed ID: 24641916
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil.
da Silva NM; Germano FN; Vidales-Braz BM; Carmo Zanella Rd; dos Santos DM; Lobato R; de Martinez AM
Cytokine; 2015 Jun; 73(2):253-7. PubMed ID: 25797191
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
15. Homozygosity for HLA group 2 alleles predicts treatment failure with interferon-α and ribavirin in chronic hepatitis C virus genotype 1 infection.
Collison M; Chin JL; Abu Shanab A; Mac Nicholas R; Segurado R; Coughlan S; Connell J; Carr MJ; Merriman RB; McCormick PA; Hall WW
J Interferon Cytokine Res; 2015 Feb; 35(2):126-33. PubMed ID: 25237729
[TBL] [Abstract][Full Text] [Related]
16. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
Persico M; Capasso M; Russo R; Persico E; Crocè L; Tiribelli C; Iolascon A
Gut; 2008 Apr; 57(4):507-15. PubMed ID: 17881539
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.
Vidigal PG; Germer JJ; Zein NN
J Hepatol; 2002 Feb; 36(2):271-7. PubMed ID: 11830340
[TBL] [Abstract][Full Text] [Related]
19. Mannose-binding lectin in chronic hepatitis C in children.
Dzwonek AB; Woźniakowska-GĘsicka T; Wiśniewska-Ligier M
Scand J Gastroenterol; 2015; 50(10):1276-84. PubMed ID: 25956563
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory breast cancer: High incidence of GCC haplotypes (-1082A/G, -819T/C, and -592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients' carcinoma tissues.
Sabet S; El-Sayed SK; Mohamed HT; El-Shinawi M; Mohamed MM
Tumour Biol; 2017 Jul; 39(7):1010428317713393. PubMed ID: 28675120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
